Finasteride Market Sees Steady Growth Through 2033, Reaching $194.5 Mn
The global finasteride market is expected to experience steady growth over the next seven years. According to recent research, the market will reach USD 194.5 Mn by 2033, up from USD 150.0 Mn in 2026, registering a compound annual growth rate (CAGR) of 3.8% during this period.
The market is driven by the increasing demand for finasteride, a medication used to treat benign prostatic hyperplasia (BPH) and male pattern baldness. The report highlights key trends, including emerging opportunities in the dermatology and urology clinics sectors.
Market leaders, such as Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., and Sandoz Group AG, are expected to maintain their market share due to their strong product portfolios and strategic business initiatives.